Skip to main content
. 2017 Nov 29;3(1):29–38. doi: 10.1177/2396987317746003

Table 2.

Proportion of patients with non-haemorrhage-related END (nhEND) and adjusted odds ratios (aORs) for nhEND by site of arterial occlusion at baseline.

Site of occlusion nhEND n/N nhEND % (95% CI) P aOR (95% CI) for nhEND P
ICA-T or ICA+MCA 6/20 30.0 (14.6–51.9) <0.001 10.3 (4.3–24.9) <0.001
ICA 16/96 16.7 (10.5–25.4) <0.001 4.3 (2.5–7.7) <0.001
ACA 2/12 16.7 (4.7–44.8) 0.008 5.9 (1.6–22.1) 0.008
MCA-M1 8/86 9.3 (4.8–17.3) 0.002 2.1 (0.97–4.4) 0.061
MCA-M2 8/137 5.8 (3.0–11.1) 0.091 1.6 (0.8–3.1) 0.14
MCA-M3 0/35 0.0 (0.0–9.9) 0.287 0.6 (0.1–4.2) 0.57
PCA 1/46 2.2 (0.4–11.3) 0.709 0.4 (0.1–3.2) 0.41
Basilar 3/29 10.3 (3.6–26.4) 0.030 2.0 (0.6–6.6) 0.26
Vertebral 4/56 7.1 (2.8–17.0) 0.098 2.3 (0.96–5.5) 0.063
Site unspecified 5/70 7.1 (3.1–15.7) 0.094 2.7 (1.3–5.7) 0.007
Any occlusion 53/587 9.0 (7.0–11.6) <0.001 2.5 (1.7–3.4) <0.001
No occlusion 55/1749 3.1 (2.4–4.1) Ref. Ref. Ref.

ACA: anterior cerebral artery; ICA-T: terminal internal carotid artery; ICA+MCA: tandem ICA and middle cerebral artery occlusion; M1, M2, M3: first, second, and third segments of the MCA; PCA: posterior cerebral artery; nhEND: increase in NIHSS score ≥4 at 24 h with no PH on follow-up imaging within 22–36 h; Ref: reference. Patients with no visible arterial occlusion on baseline CTA/MRA were used as reference for comparison.